Skip to search formSkip to main contentSkip to account menu

borrelidin

Known as: 2-(7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxooxacyclooctadeca-4,6-dien-2-yl)-cyclopentanecar boxylic acid 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
In a screening programme for search of antibiotics active against clinical resistant strains of infectious bacteria, a potent… 
2006
2006
We report the directed biosynthesis of borrelidin analogues and their selective anti-proliferative activity against human cancer… 
2004
2004
SummaryIn yeast cells grown in the presence of Borrelidin the threonyl-tRNA-synthetase is inhibited and a specific derepression… 
Highly Cited
2003
Highly Cited
2003
The first total synthesis of the natural product borrelidin is described. The propionate fragment of the molecule was concisely… 
Highly Cited
2003
Highly Cited
2003
Borrelidin, an antibiotic with anti-angiogenic activity, not only suppresses new capillary tube formation, but also collapses… 
Highly Cited
2003
Highly Cited
2003
Functional evidence for programmed loss of co-linearity on the borrelidin modular polyketide synthase (PKS) is presented. 
2001
2001
We identified borrrelidin, a member of macrolide antibiotic, as an inhibitor of a cyclin-dependent kinase of the budding yeast… 
Highly Cited
1997
Highly Cited
1997
Borrelidin, an antibiotic from Streptomyces rochei, was found to be an angiogenesis inhibitor in a rat aorta matrix culture model… 
1981
1981
The growth of Chinese hamster ovary cells in medium containing reduced concentrations of threonine is inhibited by borrelidin, a… 
1965
1965
Isolation of Vivomycin and Borrelidin, Two Antibiotics with Anti-Viral Activity, from a Species of Streptomyces (C2989)